Statistics for Globus Medical (id:9044 GMED)
Valuation metrics
Market cap
11.04B
Enterprise value
10.88B
Trailing P/E (ttm)
130.81
Forward P/E
23.71
PEG ratio
23.71
Price/Sales (ttm)
4.46
Price/Book (mrq)
2.71
Enterprise Value/Revenue
4.39
Enterprise Value/EBITDA
16.69
Overview
Shares outstanding
113.74M
Float
112.80M
Shares short
2.86M
% Held by insiders
0.01%
% Held by institutions
0.82%
Average volume (10 days)
1.48M
Average volume (90 days)
Price summary
52-Week low
44.02
52-Week high
84.87
52-Week change
44.65%
Beta
1.17
50-Day moving average
73.36
200-Day moving average
64.56
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
3.69%
Operating margin
17.67%
Operational effectiveness
Return on assets
4.73%
Return on equity
2.22%
Income statement
Revenue (ttm)
18.22
Revenue per share (ttm)
18.22
Quarterly revenue growth (yoy)
50.94
Gross profit (ttm)
1.02B
EBITDA
464.20M
Net income to common (ttm)
91.51M
Diluted EPS (ttm)
0.62
Quarterly earnings growth (yoy)
5.09K%
Balance sheet
Total cash (mrq)
694.71M
Total cash per share (mrq)
5.10
Total debt (mrq)
536.30M
Total Debt/Equity (mrq)
13.18
Current ratio (mrq)
251.40%
Book value per share (mrq)
29.94
Cash flow
Cash flow statement
414.97M
Levered free cash flow (LFCF)
473.36M